News
Further warning on SGLT2 inhibitor use and DKA risk in COVID-19
January 19, 2021
Five new cases of euglycemic diabetic ketoacidosis seen in T2D patients with acute COVID-19 illness.
![1]()
News
DOACs show safety benefit in early stages of CKD
January 15, 2021
In terms of efficacy and bleeding risk, what is known about anticoagulation in patients with chronically impaired renal function?
News
New eGFR equation ‘less biased’ by age, kidney function; some disagree
November 10, 2020
The European Kidney Function Consortium equation surpasses existing equations by "resulting in generally lower bias across the spectrum of age and kidney function," according to its developers.
![1]()
News
PICC lines often used inappropriately in advanced CKD patients
October 26, 2020
How common is peripherally inserted central catheter (PICC) use in patients with advanced chronic kidney disease (CKD), and are there associated complications?
![1]()
News
Dapagliflozin’s CKD performance sends heart failure messages
October 5, 2020
The recently reported DAPA-CKD trial results focused on patients with renal disease, but the findings also resonate for heart failure clinicians.
![1]()
News
DAPA-CKD resets eGFR floor for safe SGLT2 inhibitor use
September 25, 2020
Until now, SGLT2 inhibitors were for patients with an eGFR of at least 30 mL/min per m2. New evidence moves the threshold down to 25.
News
Deaths sky high in hospitalized COVID patients with kidney injury
September 9, 2020
“We may be facing an epidemic of post–COVID-19 kidney disease and that, in turn, could mean much greater numbers of patients who require kidney dialysis and even transplants.”
![1]()
News
DAPA-CKD: SGLT2 inhibitor benefit extends to chronic kidney disease without diabetes
August 31, 2020
DAPA-CKD showed that dapagliflozin helps patients with albuminuria and declining eGFR levels whether or not they have type 2 diabetes.
![1]()
News
Real-world data show SGLT2 inhibitors for diabetes triple DKA risk
July 29, 2020
The findings are based on the use of three different SGLT2 inhibitors in Canada and the United Kingdom.
![1]()
News
One-year mortality after dialysis initiation nearly double prior estimates
July 3, 2020
What is the 1-year mortality rate after dialysis initiation in patients older than age 65 years?
